纳特拉基因检测 NTRA
$310.67 −$53.09 (-14.59%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $311.20 +0.17%
开盘$319.99
昨收$363.76
当日区间$304.00 – $327.53
成交量5.78M
市值$45.05B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数16
平均目标价$429.28+38.2% 较现价
- 买入 94%
- 持有 6%
最低 $330.00现价 $310.67均值 $429.28最高 $500.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$355.00至$500.00，平均为$445.25。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 6 Nov 2026 | CCORF | BUY | $500.00 |
| 6 Nov 2026 | BTIG | BUY | $430.00 |
| 6 Nov 2026 | Barclays | BUY | $475.00 |
| 6 Nov 2026 | RBC Capital | BUY | $460.00 |
| 6 Nov 2026 | J.P. Morgan | BUY | $405.00 |
| 27 Oct 2026 | BTIG | BUY | $430.00 |
| 22 Oct 2026 | Roth MKM | BUY | $475.00 |
| 19 Oct 2026 | CCORF | BUY | $500.00 |
| 14 Oct 2026 | J.P. Morgan | BUY | $460.00 |
| 13 Oct 2026 | TD Cowen | BUY | $480.00 |
| 13 Oct 2026 | Morgan Stanley | BUY | $435.00 |
| 12 Oct 2026 | Morgan Stanley | BUY | $435.00 |
| 7 Oct 2026 | Barclays | BUY | $475.00 |
| 6 Oct 2026 | Citi | BUY | $480.00 |
| 1 Oct 2026 | Guggenheim | BUY | $475.00 |
| 24 Sep 2026 | RBC Capital | BUY | $460.00 |
| 20 Sep 2026 | Goldman Sachs | HOLD | $375.00 |
| 14 Sep 2026 | Morgan Stanley | BUY | $355.00 |
| 9 Sep 2026 | Bernstein | BUY | $365.00 |
| 9 Sep 2026 | UBS | BUY | $435.00 |
暂无评论——快来第一个聊聊 NTRA。
登录后参与讨论。